Saniona borrows USD 10m for clinical studies

The loan will be used to finance the clinical development of the biotech company's assets.
Rami Levin, President & Chief Executive Officer of Saniona | Photo: Saniona / PR
Rami Levin, President & Chief Executive Officer of Saniona | Photo: Saniona / PR
BY MIKKEL AABENHUS HEMMINGSEN, TRANSLATED BY CATHERINE BRETT

Biotech company Saniona has secured resources to continue the development of the company's assets as well as support general operations.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading